This combination product pairs two well-characterized research peptides: BPC-157, a 15-amino-acid gastric pentadecapeptide, and TB-500, a 43-amino-acid fragment of thymosin beta-4. Each compound has been independently investigated in published preclinical literature, and this formulation supports research into their combined profiles in laboratory settings.

Supplied as a lyophilized blend containing 5mg BPC-157 and 5mg TB-500, this product is intended exclusively for controlled in-vitro laboratory research by qualified professionals.

Chemical Information:

• BPC-157: Pentadecapeptide, GEPPPGKPADDAGLV, MW 1419.55 g/mol
• TB-500: Synthetic fragment of thymosin beta-4, MW ~4963 g/mol (full sequence)
• Combined Formulation: Dual-peptide research blend
• Compound Class: Synthetic peptide combination; tissue repair research

Research Applications:

• Dual-peptide interaction studies in cell culture and biochemical assays
• In-vitro evaluation of peptide blend stability and compatibility
• Laboratory assessment of actin-binding and nitric oxide pathway modulation
• Comparative analysis of single-peptide versus combination profiles in cellular models

Storage and Handling:

• Store at -20°C for extended preservation or 2-8°C for short-term use
• Protect from light; maintain tightly sealed containers
• Use sterile, pyrogen-free water for reconstitution
• Handle with appropriate laboratory safety and aseptic techniques

Product Specifications:

• Purity: ≥98% (HPLC, each peptide)
• Appearance: White lyophilized powder
• Form: Lyophilized powder
• Quantity: 5mg BPC-157 + 5mg TB-500 (10mg total)

Compliance Notice:
FOR RESEARCH USE ONLY — Not for human or veterinary consumption. This product is not a drug, food, cosmetic, or dietary supplement and has not been evaluated by the Food and Drug Administration for any purpose.